SEARCH

SEARCH BY CITATION

References

  • Adams, E. (1994) Postoperative thrombocytosis. Archives of Internal Medicine, 73, 329.
  • Beer, J.H., Buchi, L., Steiner, B. (1994) Glycocalicin: a new assay-the normal plasma levels and its potential usefulness in selected diseases. Blood, 3, 691702.
  • Broudy, V.C., Lin, N.L.S., Abath, D.F., Papayannopoulou, T., Kaushansky, K. (1997) Human platelets display high affinity receptors for thrombopoietin. Blood, 89, 18961904.
  • Cerutti, A., Custodi, P., Duranti, M., Noris, P., Balduini, C.L. (1997) Thrombopoietin levels in patients with primary and reactive thrombocytosis. British Journal of Haematology, 99, 281284.
  • Cerutti, A., Custodi, P., Duranti, M., Cazzola, M., Balduini, C.L. (1999) Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant. Clinical Laboratory and Haematology, 21, 271275.
  • Choi, E.S., Hokom, M., Bartley, T., Li, Y.S., Ohashi, H., Kato, T., Nichol, J.L., Skrine, J., Knudten, A., Chen, J., Hornkohl, A., Grampp, G., Sleeman, L., Cole, S., Trail, G., Hunt, P. (1995) Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-mpl, produces functional platelets in vitro. Stem Cells, 12, 317322.
  • Christenson, J.T., Gras, P.A., Grosclaude, A., Simonet, F., Schmuziger, M. (1996) Reactive thrombocytosis following coronary artery bypass surgery: a possible link to a lipid dysfunction. Journal of Cardiovascular Surgery (Torino), 37, 491498.
  • Coller, B.S., Kalomiris, E., Steinberg, M., Scudder, L.E. (1984) Evidence that glycocalicin circulates in normal plasma. Journal of Clinical Investigations, 73, 794799.
  • Cramer, E.M., Norol, F., Guichard, J., Breton-Gorius, J., Vainchenker, W., Masse, J.M., Debili, N. (1997) Ultrastructure of platelet formation by human megakaryocytes cultured with the mpl ligand. Blood, 89, 23362346.
  • Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P., Vainchenker, W. (1995a) The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood, 86, 25162525.
  • Debili, N., Wendling, F., Cosman, D., Titeux, M., Florindo, C., Dusanter-Fourt, I., Schooley, K., Methia, N., Charon, M., Nador, R., Bettaieb, A., Vainchenker, W. (1995b) The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood, 85, 391401.
  • Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K., De Sauvage, F.J. (1996) Regulation of thrombopoietin levels by c-Mpl-mediated binding to platelets. Blood, 87, 21542161.
  • Fielder, P.J., Hass, P., Nagel, M., Stefanich, E., Widmer, R., Bennett, G.L., Keller, G.A., De Sauvage, F.J., Eaton, D. (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood, 89, 27822788.
  • Folman, C.C., Dem Borne, A.E.G.KR., Rensink, I.H.J.A.M., Gerritsen, W., Van Der Schoot, C.E., De Haas, M., Aarden, L. (1997) Sensitive measurements of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thrombosis and Haemostasis, 78, 12621297.
  • Folman, C.C., Linthorst, G., Van Mourik, J.A., Van Willigen, G., De Jonge, E., Levi, M., De Haas, M., Dem Borne, A.E.G.K. (2000) Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis. Thrombosis and Haemostasis, 83, 923930 .
  • Gehling, U.M., Ryder, J.W., Hogan, C.J., Hami, L., McNiece, I., Franklin, W., Williams, S., Helm, K., King, J., Shpall, E.J. (1997) Ex vivo expansion of megakaryocyte progenitors: Effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF mobilized peripheral blood. Experimental Hematology, 25, 11251139.
  • Harker, L.A., Roskos, L.K., Marzec, U.M., Carter, R.A., Cherry, J.K., Sundell, B., Cheung, E.N., Terry, D., Sheridan, W. (2000) Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood, 95, 25142522.
  • Hino, M., Nishizawa, Y., Tagawa, S., Yamane, T., Morii, H., Tatsumi, N. (1995) Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochemistry and Biophysics Research Communications, 217, 475481.
  • Hirayama, Y., Sakamaki, S., Matsunaga, T., Kuga, T., Kuroda, H., Kusakabe, T., Sasaki, K., Fujikawa, K., Kato, J., Kogawa, K., Koyama, R., Niitsu, Y. (1998) Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essental thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood, 92, 4652.
  • Hiyoyama, K., Wada, H., Shimura, M., Nakasaki, T., Katayama, N., Nishsikawa, M., Shiku, H., Tahara, T., Kato, T. (1997) Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagulation and Fibrinolysis, 8, 345349.
  • Hobisch-Hagen, P., Schobersberger, W., Luz, G., Innerhofer, P., Jelkmann, W. (1998) Circulating immunoreactive thrombopoietin increases rapidly after normovolemic hemodilution [letter]. Thrombosis and Haemostasis, 80, 718719.
  • Hsu, H.C., Tsai, W.H., Jiang, M.L., Ho, C.H., Hsu, M.L., Ho, C.K., Wang, S.Y. (1999) Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. Journal of Laboratory and Clinical Medicine, 134, 392397.
  • Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., Burstein, S.A. (1989) Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proceedings of the National Academy of Sciences of the United States of America, 86, 59635957.
  • Ishiguro, A., Ishikita, T., Shimbo, T., Matsubara, K., Baba, K., Hayashi, Y., Naritaka, S., Nakahata, T. (1998) Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thrombosis and Haemostasis, 79, 10961100.
  • Kaushansky, K. (1995) Thrombopoietin: The primary regulator of platelet production. Blood, 86, 419431.
  • Kaushansky, K., Broudy, V.C., Lin, N., Jorgensen, M.J., McCarty, J., Fox, N., Zucker-Franklin, D., Lofton-Day, C. (1995) Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proceedings of the National Academy of Sciences of the United States of America, 92, 32343238.
  • Kawasugi, K., Gotoh, M., Gohchi, K., Matuda, J., Kinoshita, T., Miyazaki, H. (1998) Increased endogenous levels of thrombopoietin and interleukin-6 without elevation of interleukin 11 in patients with DIC. (Abstract). Blood, 10, 32a.
  • Kuter, D.J. & Rosenberg, R.D. (1995) The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood, 85, 27202730.
  • Li, J., Xia, Y., Kuter, D.J. (1999) Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. British Journal of Haematology, 106, 345356.
  • Mensink, E., Van De Locht, A., Schattenberg, A., Linders, E., Schaap, N., Geurts, V.K., De Witte, T. (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. British Journal of Haematology, 102, 768774.DOI: 10.1046/j.1365-2141.1998.00823.x
  • Norol, F., Vitrat, N., Cramer, E., Guichard, J., Burstein, S.A., Vainchenker, W., Debili, N. (1998) Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood, 91, 830843.
  • O'Malley, C.J., Rasko, J.E.J., Basser, R.L., McGrath, K.M., Cebon, J., Grigg, A.P., Hopkins, W., Cohen, B., O'Byrne, J., Green, M.D., Fox, R.M., Berndt, M.C., Begley, C.G. (1996) Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of vivo activation. Blood, 88, 32883298.
  • Pepper, H. & Lindsay, S. (1960) Responses of platelets, eosinophils and total leukocytes, during and following surgical procedures. Gynecological and Obstetric Surgery, 110, 319326.
  • Porcelijn, L., Folman, C.C., Bossers, B., Huiskes, E., Overbeeke, M.A.M., Van Der Schoot, C.E., De Haas, M., Dem Borne, A.E.G.KR. (1998) The diagnostic value of thrombopoietin levels measurements in thrombocytopenia. Thrombosis and Haemostasis, 79, 11011105.
  • Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet, 355, 12951302.DOI: 10.1016/s0140-6736(00)02110-3
  • Robbins, G. & Barnard, D.L. (1983) Thrombocytosis and microthrombocytosis: a clinical evaluation of 372 cases. Acta Haematologica, 70, 175182.
  • Rood, P.M.L., Von Calafat, J., Dem Borne, A.E.G.K., Gerritsen, W., Van Der Schoot, C.E. (2000) Immortalization of human bone-marrow endothelial cells: characterization of new cell lines. European Journal of Clinical Investigation, 30, 619629.
  • Sakamaki, S., Hirayama, Y., Matsunaga, T., Kuroda, H., Kusakabe, T., Akiyama, T., Konuma, Y., Sasaki, K., Tsuji, N., Okamoto, T., Kobune, M., Kogawa, K., Kato, J., Takimoto, R., Koyama, R., Niitsu, Y. (1999) Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity. Blood, 94, 19611970.
  • Schmuziger, M., Christenson, J.T., Maurice, J., Simonet, F., Velebit, V. (1995) Reactive thrombocytosis after coronary bypass surgery. An important risk factor. European Journal of Cardiothoracic Surgery, 9, 393397.
  • Steinberg, M.H., Kelton, J.G., Coller, B.S. (1987) Plasma glycocalicin. An aid in the classification of thrombopenic disorders. New England Journal of Medicine, 317, 10371042.
  • Stoffel, R., Wiestner, A., Skoda, R.C. (1996) Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567573.
  • Stohlawetz, P., Von Folman, C.C., Dem Borne, A.E.G.K., Pernerstorfer, T., Eichler, H.G., Panzer, S., Jilma, B. (1999) Effects of endotoxemia on thrombopoiesis in men. Thrombosis and Haemostasis, 81, 613617.
  • Sungaran, R., Markovic, B., Chong, B.H. (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney,liver, bone marrow, and spleen using in situ hybridization. Blood, 89, 101107.
  • Sungaran, R., Chisholm, O.T., Markovic, B., Khachigian, L.M., Tanaka, Y., Chong, B.H. (2000) The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood, 95, 30943101.
  • Uppenkamp, M., Makarova, E., Petrasch, S., Brittinger, G. (1998) Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Annals of Hematology, 77, 217223.DOI: 10.1007/s002770050446
  • Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D., Vainchenker, W. (1994) c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571574.
  • Wolber, E.M. & Jelkman, W. (2000) Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B. Journal of Interferon and Cytokine Research, 20, 499506.
  • Yang, C., Xia, Y., Kuter, D.J. (1997) The HepG2 cell as a model system for studying thrombopoietin production and regulation. Blood, 90 suppl. 1, 3427(abstract).